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Abstract
It has been shown by a number of authors that the radiosensitivity of peripheral blood mononuclear cells (PBMC)
is higher in cancer patients compared to healthy donors, which is interpreted as a sign of genomic instability.
PBMC are composed of different cell subpopulations which are differently radiosensitive and the difference
between cancer patients and healthy donors could also be due to different composition of their PBMC pools.
Gamma-delta T-lymphocytes play an important role in immunosurveillance and are promising cells for immuno-
therapy. Their abundance is frequently reduced in cancer patients so should their sensitivity to radiation be lower
than that of other T-lymphocytes, this could, at least partly explain the low radiosensitivity of PBMC from healthy
individuals compared to cancer patients. The present investigation was carried out to test this. Using the alkaline
comet assay we analysed the level of DNA damage and repair in isolated gδ T-lymphocytes, pan T-lymphocytes
and in total PBMC exposed in vitro to gamma radiation. We found no difference in the level of DNA damage and
the capacity of DNA repair between the T cell populations. This is the first study that addresses the question of
sensitivity to radiation of gamma-delta T-cells.
Background
Human peripheral blood mononuclear cells (PBMC) are
used as surrogate tissue for the assessment of individual
sensitivity to ionising radiation [1]. Using the G2
chromosomal aberration assay it has been shown by a
number of authors that the radiosensitivity of PBMC is
higher in cancer patients compared to healthy donors
[2-9]. A similar result was reported using the micro-
nucleus assay [10] and the comet assay [11,12] and is
generally interpreted as a reflection of genomic instabil-
ity in PBMC of cancer patients [10].
PBMC are composed of different cell subpopulations
which are differently radiosensitive. It is generally
accepted that B lymphocytes show a higher radiosensi-
tivity than T-lymphocytes that are all CD3+ [13-16].
Among the T-lymphocytes cytotoxic CD8+ cells appear
somewhat more sensitive than helper CD4+ cells
[16,17], although this was not observed in all studies
[18]. A lymphocyte subpopulation which recently
attracted interest is composed of T-lymphocytes with gδ
T-cell receptors (TCR). The reason for this is the dis-
covery that these cells contribute to immunity against
cancer [19]. In peripheral blood gδ lymphocytes account
for less than 5% of total T-lymphocytes while their
proportion in the intestine can be much higher [20].
Given their role in immunosurveillance, the level
and/or the activity of gδ T-lymphocytes is expected to
be low in PBMC of cancer-prone individuals and high
in PBMC of individuals who are resistant to cancer.
This is supported by findings in patients with lym-
phoma, myeloma, breast and nasopharyngeal carci-
noma [21-23]. Should the sensitivity to radiation of gδ
lymphocytes be lower than that of the more common
ab T-lymphocytes, this could, at least partly explain
the low radiosensitivity of PBMC from healthy indivi-
duals compared to cancer patients. The present inves-
tigation was carried out to test if there are differences
in the radiation sensitivity between different TCR sub-
type populations by comparing the level of DNA
damage and the kinetics of DNA repair in isolated gδ
T-lymphocytes, pan T-lymphocytes and in total PBMC
exposed in vitro to gamma radiation. Experiments
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were exposed to the moderate dose of 1 Gy at 37°C.
Results
We decided to analyse the percentage of DNA in the
tail (% TDNA) as marker of damage [24]. The control
% TDNA values did not differ significantly between 0
and 60 min of incubation at 37°C (Figure 1). The aver-
age level of spontaneous damage was highest in gδ
T-lymphocytes and it was significantly higher than in
pan T-lymphocytes. The differences between gδ T-lym-
phocytes and PBMC, as well as between pan T-lympho-
cytes and PBMC were not significant.
The % TDNA values found in the control cells were
subtracted from the radiation-induced values. The net
radiation-induced % TDNA values as a function of
repair time are shown in figure 2. No consistent differ-
ence between the cell subpopulations was observed for
the initial level of DNA damage. DNA repair proceeded
in all cell types at a similar rate and following 60 min of
repair the majority of DNA damage was repaired. No
consistent difference between the cell subpopulations
was observed for the residual level damage.
An advantage of the comet assay is the ability to
analyse DNA damage in individual cells. Although we
observed no difference in the mean level of DNA
damage between the analysed cell subpopulations, it is
possible that differences existed in the distribution pat-
terns of cells with different level of DNA damage. In
order to check this, cells were grouped into classes of
% TDNA values and plotted on one graph. The results
for 0 and 60 min repair are shown in figure 3. The
distribution patterns of all three cell populations look
similar.
Discussion
It has been proposed that the in vitro radiosensitivity of
PBMC correlates with individual sensitivity to ionising
radiation [1] and it has been shown that the in vitro
radiosensitivity of PBMC is higher in cancer patients
compared to healthy donors [2-12]. The mechanisms
behind these observations are not known. One factor
could be a different composition of lymphocyte subsets
in PBMC collected for analysis from radiosensitive and
radioresistant donors.
Differences in the radiosensitivity of lymphocyte sub-
sets have been demonstrated, although the results are
contradictory. A high sensitivity of B-, as compared to
T-lymphocytes has generally been found (see [14,16]
and the literature within), whereas one study found no
difference between the subsets after high doses of
gamma radiation and after exposure of cells to neu-
trons [15]. Both Wilkins et al. [17] and Schmitz et al.
[16] observed a somewhat higher sensitivity in CD8+
than in CD4+ T-lymphocytes. No difference between
CD8+ and CD4+ T-lymphocytes was observed by
Louagie at al. [18], who however, found that both
CD8+ and CD4+ T-cells were more radiosensitive than
NK cells. In these studies, ab and gδ T-cells were not
separated meaning that the bulk of both CD8+ and
CD4+ T-lymphocytes would have had the ab receptor.
We have, for the first time, compared the radiosensi-
tivity of gδ T-lymphocytes with that of pan T-lympho-
cytes and PBMC. Pan T-lymphocytes are composed of
both ab and gδ T-lymphocytes, however, the fraction
of the latter in lymphocytes of our donors was not
higher than 3% (not shown), so their influence on the
radiosensitivity of pan T-lymphocytes is negligible. We
found no difference in the level of radiation-induced
DNA damage and the capacity of DNA repair between
the cell populations.
Our result shows that the low radiosensitivity of
PBMC isolated from healthy donors compared to can-
cer patients, can not be due to a high level of gδ
T-lymphocytes in the peripheral blood of the former.
This does not exclude the possibility that the differ-
ence in radiosensitivity results from a different compo-
sition of lymphocyte subpopulations in healthy and
cancer patients. However, thisp o s s i b i l i t yh a sh i t h e r t o
not been studied.
An interesting finding was that the level of sponta-
n e o u sD N Ad a m a g ew a sh i g h e ri ngδ T-lymphocytes
than in pan T-lymphocytes and in PBMC. This finding
is somewhat difficult to interpret. The essential factor
determining whether a segment of DNA appears in the
tail rather than in the head of a comet is the relaxation
Figure 1 Spontaneous levels of DNA damage measured after 0
min and 60 min of incubation time. Error bars: standard
deviations from the mean % TDNA values. PT: pan T, GD: gamma-
delta, PBMC: peripheral blood mononuclear cells, ns: non significant.
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damage [24]. This would suggest that gδ T-lymphocytes
suffer from a high level of spontaneous DNA damage.
The reason for this is unclear and in our opinion the
result should be treated with caution. Obviously, it must
be validated by more studies.
An observation that requires a comment is the large
scatter of the comet results as seen in figure 2. We
scored the slides in a blind manner and the large stan-
dard deviations are due to the presence of both intact
and damaged cells on the same slide. We tried to reduce
the scatter by eliminating from analysis an equal num-
ber of cells with lowest and highest level of damage, but
the standard deviations remained broad. A lower scatter
would possibly be found if we used a higher dose of
radiation than 1 Gy. This would lead to a higher level of
DNA damage. However, we intentionally kept the dose
at 1 Gy, because of the known high radiosensitivity of
some lymphocyte subsets [25]. In our opinion a dose
higher than 1 Gy could have damaged the lymphocytes
to an extent that would make the results unreliable.
It should be stressed that despite our negative results
related to the sensitivity of cells to radiation, gδ T-lym-
phocytes, in particular those having the g9δ2T C R ,a r e
interesting cells to exploit for immunotherapy because
they specifically cause lysis of tumour cells without
affecting non transformed cells [26] and clinical trials
show promising results with gδ T lymphocyte immuno-
therapy [27]. The combination of immunotherapy with in
vitro expanded gδ T-lymphocytes and radiotherapy has
not been evaluated and is an avenue worth visiting.
Conclusions
Taken together, the results provide no evidence for dif-
ferent radiation sensitivity of gδ lymphocytes, pan
T-lymphocytes and total PBMC. This does not exclude
Figure 2 Kinetics of DNA repair in cells from three independent experiments each with with lymphocytes of one donor donor (panels
A-C) and pooled results (panel D). Net percent of DNA in tail values are shown. Error bars: standard deviations from individual cell
measurements (panels A-C) and from the mean % TDNA values (panel D). PT: pan T, GD: gamma-delta, PBMC: peripheral blood mononuclear
cells.
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radiosensitivity of PBMC between cancer patients and
healthy donors results from a different composition of
lymphocyte subpopulations.
Methods
Isolation of human peripheral mononuclear cells and
T-lymphocytes
Experiments were performed with PBMC isolated from
three healthy volunteers: donor 1 (male, aged 49, non-
smoker), donor 2 (male, aged 53, non-smoker) and
donor 3 (male, aged 40, non-smoker). The study was
approved by the local ethical committee. Written
informed consent was obtained from the volunteers for
publication. A copy of the written consent is available
for review by the Editor-in-Chief of this journal. Three
independent experiments were performed, each with
blood of one donor.
PBMCs were isolated from 80 ml fresh blood on a his-
topaque gradient. Pan T cells (CD3+, containing both
ab and gδ T-lymphocytes) were isolated from 6 × 10
6
PBMCs that were mixed with pan T-cell isolation beads
according to the manufacturers instructions (Miltenyi
Biotec Inc., Auburn, CA). T-lymphocytes being CD3+
Figure 3 Distributions of comets scored after 0 min repair (initial damage - panel A) and 60 min repair (residual damage - panel B).
Cells were grouped into classes of percent of DNA in tail values. Pooled results from three experiments. Error bars: standard deviations from
independent experiments. PT: pan T, GD: gamma-delta, PBMC: peripheral blood mononuclear cells.
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6
PBMCs were kept for further experiments and pan gδ
T-cells were purified from the remainder of the PBMCs
assuming that 10% were gδ T-cells and adjusting the
manufacturers protocol accordingly (Miltenyi Biotec
Inc., Auburn, CA). gδ+ cells were positively selected on
a MACS column. The cells were counted in trypan blue
in a Countess Automatic Cell Counter (Intvitrogen,
Carlsbad, CA) and kept at 1 × 10
6 per ml in RPMI med-
ium supplemented with 2 mM L-glutamine, 100 U/ml
penicillin and 100 mg/ml streptomycin at 37°C in humi-
dified incubator under 5% CO2 and used within twenty
hours for the comet assay.
Irradiation and comet assay
Irradiation was carried out using a Scanditronix
(Uppsala, Sweden)
137Cs source operating at 0.47 Gy/
min. Cells were transferred to 1.5 ml Eppendorf cups,
placed in 37°C water cups, irradiated with a dose of
1 Gy and immediately placed on ice to stop DNA repair.
Following incubation on ice cells were kept at 37°C for
0, 15, 30 and 60 min and processed for the alkaline
comet assay [28]. Two non-irradiated samples per cell
type and experiment were analysed as controls following
incubation at 37°C for 0 and 60 min.
Microscope slides were pre-coated with 50 μlo f0 . 5 %
normal melting agarose (BDH, Germany), and left to
dry. 1.5 × 10
5 cells were mixed 1:1 with low melting
agarose (US, Belgium) at 37°C, 100 μl of this suspension
was placed on a pre-coated slide, covered with a cover-
slip and left to solidify at +4°C for 5 min. Thereafter the
coverslips were removed and the rest of the assay was
conducted at +4°C, to ensure gel stability, using only
red light as the light source. The slides were immersed
in lysis buffer (2.5 M NaCl, 100 mM Na2EDTA, 10 mM
Tris, 1% Triton X-100, pH 10.0) for 1 hour, followed by
a brief washing step in double distilled H2Of o r5m i n .
The slides were then placed in an EC 340 Maxicell
Primo (Thermo EC, Holbrook, USA) electrophoresis
tank containing 1.31 L unwinding/electrophoresis buffer
(1 mM Na2EDTA, 300 mM NaOH, pH 13.3). After 1 h
of incubation the power supply unit (Kyoritsu P 103B,
Tokyo, Japan) was switched on and ran at 32.5 V (1 V/
cm), 430 mA for 25 minutes. The number of slides in
the unit was constant for all experiments.
Following electrophoresis, slides were washed in neu-
tralization buffer (0.4 M Tris), stained with 1 μMD A P I
(in water, Sigma-Aldrich), covered with coverslips and
stored in the dark at +4°C in a humid container until
analysis the following day. Comets were scored blind
using a 40× objective on a Nikon Eclipse E800 (Nikon,
Tokyo, Japan) fluorescence microscope. Images were
acquired and analyzed using the Comet II software
(Perspective Instruments, Suffolk, UK, version 2.11).
50 cells per experiment and point were analysed.
Statistical analysis
The Comet II software yields Excel data sheets with the
measurement results for each cell from a treatment
group. We focused on analysing % TDNA as the marker
of damage. In order to reduce data scatter, the results
obtained for each treatment point were processed as
follows: the % TDNA values were sorted in raising order
and 5 lowest and 5 highest values were deleted. This
procedure was carried out for every treatment group
including the control samples. Thus, the number of cells
analysed was reduced to 40. For the analysis of radia-
tion-induced level of % TDBA, the mean (from 0 and
60 min incubation time) control level of % TDNA was
subtracted.
The average values from individual experiments were
compared using the 2 tailed Student’s t-test.
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